Vivici's Innovation in Active Nutrition: A New Era with Precision Fermentation
In a significant advancement for the active nutrition industry, Vivici, the joint venture of Fonterra and dsm-firmenich, is making strides with its innovative protein product, Vivitein BLG. This ingredient, rooted in precision fermentation technology, aims to revolutionize protein applications in health and fitness sectors.
According to Global Data and LEK Consulting, the market for active nutrition was valued at $28.4 billion globally in 2023, with an impressive growth of 8.5% that same year. Vivitein BLG is positioned to serve this expanding market, offering clear water-based protein drinks, clean protein powders, and vegan-friendly bars with the texture of traditional ingredients.
This groundbreaking ingredient will be showcased at Expo West 2025 in Anaheim, CA. CEO Stephan van Sint Fiet reveals that initial customer agreements are in place, with commercial supplies already underway. Retail products are anticipated to hit shelves soon.
History
Founded in 2023, Vivici has secured a substantial €32.5 million in Series A funding. This investment is driven by major players like APG on behalf of ABP and supported by entities such as Invest-NL and InnovationQuarter, alongside ongoing backing from Fonterra and dsm-firmenich.
This backing sets Vivici apart from its competitors in the protein market due to its unique blend of cutting-edge biotechnology and extensive dairy protein expertise.
Sustainability
Vivici’s Vivitein BLG embodies a sustainable solution for the protein needs of the growing global population. By utilizing precision fermentation, the product boasts a remarkable 86% reduction in water usage and a 68% lower carbon footprint compared to conventional dairy protein production methods.
Van Sint Fiet emphasizes Vivici’s commitment to sustainability, stating the company's ambition to set a new standard in the protein industry. Additionally, Vivici plans to enhance its production capabilities with a U.S. manufacturing partner and aims to release a lactoferrin ingredient, Vivitein LF, later this year.
